Cargando…

Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study

BACKGROUND: Partial tears of the anterior cruciate ligament (ACL) are frequent, and there is still considerable controversy surrounding their diagnosis, natural history and treatment. AIM: To examine patient-reported outcomes, physical examination and magnetic resonance imaging (MRI) findings of par...

Descripción completa

Detalles Bibliográficos
Autores principales: Zicaro, Juan Pablo, Garcia-Mansilla, Ignacio, Zuain, Andres, Yacuzzi, Carlos, Costa-Paz, Matias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223727/
https://www.ncbi.nlm.nih.gov/pubmed/34189080
http://dx.doi.org/10.5312/wjo.v12.i6.423
_version_ 1783711752892973056
author Zicaro, Juan Pablo
Garcia-Mansilla, Ignacio
Zuain, Andres
Yacuzzi, Carlos
Costa-Paz, Matias
author_facet Zicaro, Juan Pablo
Garcia-Mansilla, Ignacio
Zuain, Andres
Yacuzzi, Carlos
Costa-Paz, Matias
author_sort Zicaro, Juan Pablo
collection PubMed
description BACKGROUND: Partial tears of the anterior cruciate ligament (ACL) are frequent, and there is still considerable controversy surrounding their diagnosis, natural history and treatment. AIM: To examine patient-reported outcomes, physical examination and magnetic resonance imaging (MRI) findings of partial ACL tears treated with an intraarticular injection of platelet-rich plasma (PRP) compared to a control group. METHODS: From January 2015 to November 2017, consecutive patients from a single institution with partial ACL tears treated nonoperatively were prospectively evaluated. Partial tears were defined as a positive Lachman test with a clear end-point, a negative pivot-shift and less than 3 mm of side-to-side difference using the KT1000 arthrometer. Patients in group 1 were treated with one intraarticular injection of PRP and specific physical therapy protocol. Control group consisted of patients treated only with physical therapy. Prospective analyzed data included physical examination, Tegner activity level and Lysholm and International Knee Documentation Committee scores. Baseline MRI findings and at 6 mo follow-up were reviewed. Failure was defined as those patients with clinical instability at follow-up that required a subsequent ACL reconstruction. RESULTS: A total of 40 patients where included, 21 treated with PRP injection with a mean follow-up of 25 mo [standard deviation (SD): 3.6] and 19 in the control group with a mean follow-up of 25 mo (SD: 5.68). Overall failure rate was 32.0% (n = 13). No significant differences were observed between groups regarding subjective outcomes, return to sport and failure rate. MRI findings revealed an improvement in the ACL signal in half of the patients of both groups. However, we did not find a significant relationship between MRI findings and clinical outcomes. CONCLUSION: Overall, 95.0% of patients returned to sports at a mean follow-up of 25 mo. Mean time to return to sports was 4 mo. Out of these patients, almost 30.0% in each group had a new episode of instability and required surgery at a median time of 5 mo in group 1 and 8 mo in group 2. The addition of PRP alone was not sufficient to enhance any of the outcome measures evaluated, including MRI images, clinical evaluation and failure rate.
format Online
Article
Text
id pubmed-8223727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-82237272021-06-28 Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study Zicaro, Juan Pablo Garcia-Mansilla, Ignacio Zuain, Andres Yacuzzi, Carlos Costa-Paz, Matias World J Orthop Prospective Study BACKGROUND: Partial tears of the anterior cruciate ligament (ACL) are frequent, and there is still considerable controversy surrounding their diagnosis, natural history and treatment. AIM: To examine patient-reported outcomes, physical examination and magnetic resonance imaging (MRI) findings of partial ACL tears treated with an intraarticular injection of platelet-rich plasma (PRP) compared to a control group. METHODS: From January 2015 to November 2017, consecutive patients from a single institution with partial ACL tears treated nonoperatively were prospectively evaluated. Partial tears were defined as a positive Lachman test with a clear end-point, a negative pivot-shift and less than 3 mm of side-to-side difference using the KT1000 arthrometer. Patients in group 1 were treated with one intraarticular injection of PRP and specific physical therapy protocol. Control group consisted of patients treated only with physical therapy. Prospective analyzed data included physical examination, Tegner activity level and Lysholm and International Knee Documentation Committee scores. Baseline MRI findings and at 6 mo follow-up were reviewed. Failure was defined as those patients with clinical instability at follow-up that required a subsequent ACL reconstruction. RESULTS: A total of 40 patients where included, 21 treated with PRP injection with a mean follow-up of 25 mo [standard deviation (SD): 3.6] and 19 in the control group with a mean follow-up of 25 mo (SD: 5.68). Overall failure rate was 32.0% (n = 13). No significant differences were observed between groups regarding subjective outcomes, return to sport and failure rate. MRI findings revealed an improvement in the ACL signal in half of the patients of both groups. However, we did not find a significant relationship between MRI findings and clinical outcomes. CONCLUSION: Overall, 95.0% of patients returned to sports at a mean follow-up of 25 mo. Mean time to return to sports was 4 mo. Out of these patients, almost 30.0% in each group had a new episode of instability and required surgery at a median time of 5 mo in group 1 and 8 mo in group 2. The addition of PRP alone was not sufficient to enhance any of the outcome measures evaluated, including MRI images, clinical evaluation and failure rate. Baishideng Publishing Group Inc 2021-06-18 /pmc/articles/PMC8223727/ /pubmed/34189080 http://dx.doi.org/10.5312/wjo.v12.i6.423 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Prospective Study
Zicaro, Juan Pablo
Garcia-Mansilla, Ignacio
Zuain, Andres
Yacuzzi, Carlos
Costa-Paz, Matias
Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title_full Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title_fullStr Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title_full_unstemmed Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title_short Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
title_sort has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? prospective comparative study
topic Prospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223727/
https://www.ncbi.nlm.nih.gov/pubmed/34189080
http://dx.doi.org/10.5312/wjo.v12.i6.423
work_keys_str_mv AT zicarojuanpablo hasplateletrichplasmaanyroleinpartialtearsoftheanteriorcruciateligamentprospectivecomparativestudy
AT garciamansillaignacio hasplateletrichplasmaanyroleinpartialtearsoftheanteriorcruciateligamentprospectivecomparativestudy
AT zuainandres hasplateletrichplasmaanyroleinpartialtearsoftheanteriorcruciateligamentprospectivecomparativestudy
AT yacuzzicarlos hasplateletrichplasmaanyroleinpartialtearsoftheanteriorcruciateligamentprospectivecomparativestudy
AT costapazmatias hasplateletrichplasmaanyroleinpartialtearsoftheanteriorcruciateligamentprospectivecomparativestudy